Your search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.
This CME monograph provides the latest data and recommendations regarding timely diagnosis and treatment of influenza so that clinicians are well-equipped to compare the efficacy and safety of available antiviral therapies for influenza prophylaxis and treatment. Using case examples, experts discuss strategies for incorporating the most appropriate therapeutic regimen to reduce morbidity and mortality in patients who are at high risk for influenza-related complications.
In this 1.5-hour online educational activity, interprofessional faculty will use patient cases to discuss the clinical effects of neuromuscular blocking and reversal agents, including key components of NMB and reversal during the intraoperative phase of care and neuromuscular monitoring.
In this 1 hour online educational activity, interprofessional faculty will focus on reversal strategies for neuromuscular blockade in specific high-risk patient populations as well as develop a plan for reversal based on clinical and neuromuscular patient assessments.
AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists, CPEU Credit
Patients with diabetes and PAD, particularly those with concomitant polyvascular disease, are at a greater risk for future adverse cardiovascular and limb events.
AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists, AANP Contact Hour(s), ABIM MOC Credit
The emergence of four monoclonal antibodies or therapies targeting calcitonin gene-related peptide (CGRP) has transformed the treatment of migraine. This presentation reviews the discovery of this drug class, analyzes data from clinical trials, discusses future therapies in the class, and highlights clinical pearls to help attendees better understand these therapies and integrate them into clinical practice.
AMA PRA Category 1 Credit(s)TM, CE for Pharmacists, CNE Contact Hour(s), ABIM MOC Points
In this CME Outfitters webcast, expert faculty will focus on identifying key terminology related to biosimilar products, assessing evidence regarding the efficacy and safety of biosimilars in IBD, and improving patient-provider communication patterns on the topic of biosimilars.
AMA PRA Category 1 Credit(s)TM, CE for Pharmacists
In this CME Outfitters BriefCase, expert faculty will present a patient case focusing on the impact of comorbidities and how to individualize treatment regimens for aging patients with HIV, based on their specific needs and comorbidities.
AMA PRA Category 1 Credit(s)TM, CE for Pharmacists
This CME Outfitters BriefCase focuses on incorporating the latest evidence-based and guideline-directed treatment strategies for a patient who has been newly diagnosed with HIV.
AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists
Provisional, updated Infectious Diseases Society of America (IDSA)/Society for Healthcare Epidemiology of America (SHEA) guidelines were released during ID Week® of 2020 and reflect notable changes in the treatment recommendations of Clostridioides difficile infection (CDI) that are unfamiliar to many clinicians who manage the care of individuals with CDI.
AMA PRA Category 1 Credit(s)TM, AAPA Category I CME credit, ANCC Contact Hour(s), CE for Pharmacists
Outpatient management for alcohol use disorder (AUD) can be a formidable challenge, especially in a patient who is resistant to treatment. Clinicians need to recognize multiple issues, including concerns about comorbidities and drug-drug interactions, when initiating treatment in patients recently referred from the emergency department.
AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists
Educate clinicians who care for patients with RA on the use of serological biomarkers and the guideline-driven assessment of disease severity to determine the appropriate course of disease management.
AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists
As the research of maintenance strategies in acute myeloid leukemia (AML) advances, it is important for clinicians stay abreast of study designs and results from clinical trials. This activity will discuss a patient case study and explain treatment decisions and rationale for maintenance strategies in AML.
AMA PRA Category 1 Credit(s)TM, CE for Pharmacists, CNE Contact Hour(s)
The discussion will cover pathophysiological features of obesity and how to assess efficacy and safety of available and emerging therapies for long-term treatment of obesity.
AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists, AAPA Category I CME credit
This CME Outfitters BriefCase introduces Jeff, a 31-year-old African American infected with HIV perinatally and discusses the when and how of switching antiretroviral therapy (ART) based on safety and efficacy data.
Earn up to 1.25 CNE Contact Hous and 1.25 pharmacology credits. Up-to-date information on integrating the current evidence regarding the use of supplements in children into primary care pediatric practice. Learn More.
Earn up to 1.00 CNE Contact Hour with 0.5 pharmacology credits and 1.00 psychopharmacology credit. Up-to-date information caring for children with ADHD symptoms. Learn More.
Earn up to 1.50 CNE Contact Hours and 1.50 pharmacology credits. A rapid review of current guidelines for treating pediatric infectious diseases. Learn More.
Earn up to 1.00 CNE Contact Hour and 1.00 pharmacology credit. Recommendations for use of GI drugs in the pharmacological management of common GI pathologies in children. Learn More.
Earn up to 1.50 CNE Contact Hours and 1.50 pharmacology credits. Up-to-date information on pharmacological management of common respiratory illnesses in children Learn More.
Earn up to 1.00 CNE Contact Hour and 1.00 pharmacology credits. An extensive review and update provide an improved understanding of therapeutic benefits and risks of medications prescribed for children. Learn More.
A new chapter in the fight against MS starts; now more than ever there is a need to distinguish the subtypes of MS for appropriate evaluation and treatment.
